These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3095073)

  • 41. Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria.
    Hübner J; Hartung D; Kropec A; Daschner FD
    Infection; 1991; 19(3):186-9. PubMed ID: 1889877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
    Wilkinson LD; Gentry LO
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():53-6. PubMed ID: 19802969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey.
    Erdem H; Kiliç S; Pahsa A; Besirbellioglu
    J Chemother; 2005 Feb; 17(1):61-5. PubMed ID: 15828445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.
    Stephens M; Potten M; Bint AJ
    Infection; 1979; 7(3):109-12. PubMed ID: 478651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.
    Penner JL; Preston MA; Hennessy JN; Barton LJ; Goodbody MM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):218-21. PubMed ID: 6765415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of effectiveness of antibiotics by anaerobiosis.
    Verklin RM; Mandell GL
    J Lab Clin Med; 1977 Jan; 89(1):65-71. PubMed ID: 318675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
    Just HM; Becker C; Bassler M; Daschner FD
    Chemotherapy; 1984; 30(6):387-91. PubMed ID: 6596165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of blood isolates to various antibiotics, in particular to cephalosporins.
    Ling J; Chau PY; Leung YK; Ng WS
    J Antimicrob Chemother; 1983 May; 11(5):473-80. PubMed ID: 6874632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
    Said AA; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():103-8. PubMed ID: 2732132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sensitivity of Salmonella strains to Augmentin and new generation cephalosporins and aminoglycosides].
    Dolna I; Gościniak G; Ruczkowska J
    Przegl Epidemiol; 1989; 43(2):218-22. PubMed ID: 2682793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group.
    Chamberland S; L'Ecuyer J; Lessard C; Bernier M; Provencher P; Bergeron MG
    Clin Infect Dis; 1992 Oct; 15(4):615-28. PubMed ID: 1420674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria.
    Just HM; Beckert A; Bassler M; Daschner FD
    Chemotherapy; 1982; 28(5):397-401. PubMed ID: 6291869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.
    Just HM; Becker C; Gieringer J; Wenz A; Bassler M; Daschner F
    Drugs; 1985; 29 Suppl 5():74-7. PubMed ID: 4029031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):378-89. PubMed ID: 2931927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: an 8-year survey in a University Hospital in Greece.
    Neonakis I; Gikas A; Scoulica E; Manios A; Georgiladakis A; Tselentis Y
    Int J Antimicrob Agents; 2003 Nov; 22(5):526-31. PubMed ID: 14602373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity to new generation of antibiotics in biliary surgery.
    Reiss R; Landau O; Deutsch AA; Nudelman I
    Int Surg; 1992; 77(2):96-8. PubMed ID: 1644544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
    Piédrola G; Galan I; Leyva A; Maroto MC
    Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic selective pressure and development of bacterial resistance.
    Kolár M; Urbánek K; Látal T
    Int J Antimicrob Agents; 2001 May; 17(5):357-63. PubMed ID: 11337221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.